Brief: Aker Biomarine Receives Approval For Lysovetatm As New Dietary Ingredient In The US
10/08/2023 07:33
Aug 10 (Reuters) - Aker Biomarine ASA AKBM.OL :
* AKER BIOMARINE HAS RECEIVED APPROVAL FOR LYSOVETATM AS A
NEW
DIETARY INGREDIENT IN THE US
Source text for Eikon: ID:nObiB9Y8Fa
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker ASA: Conditions For Completion Of Merger With Aker Biomarine Satisfied
Brief: Aker Capital Buys 933,110 Aker BioMarine Shares
Brief: Aker Biomarine To Hold EGM On August 17
Brief: Aker Biomarine: Optional Cash Offer To Shareholders
Brief: Aker Biomarine: Proposed Merger And Optional Cash Offer